Neurology

Neurology Patient Care Medical Research Clinical Research Public Health Research Clinical Trials Cell Biology Pharmaceuticals Regulatory Affairs

3 ARTICLES

last wk.

EHR-Based Screening Nearly Doubles Mental Health Assessments in Epilepsy Care

A new study shows anxiety and depression screenings rose from 12.6% to 29.2% in an epilepsy clinic, with plans to address demographic disparities and streamline workflows.

6 ARTICLES

last wk.

FDA Approves First Blood Test for Alzheimer’s Diagnosis

4 ARTICLES

last wk.

NIH-Led CBI-M Framework Modernizes Traumatic Brain Injury Diagnosis After 51 Years

4 ARTICLES

last wk.

Researchers Uncover Brain Ion Channel's Role in Molecular Memory

6 ARTICLES

last wk.

FDA Approves First Blood Test for Early Alzheimer’s Diagnosis in Symptomatic Adults

16 ARTICLES

last wk.

FDA Approves First Blood Test for Alzheimer’s Diagnosis

4 ARTICLES

2w ago

UCSF Research Advances Prenatal Therapy for Spinal Muscular Atrophy

3 ARTICLES

2w ago

AAN Highlights Gaps in Evidence for FDA-Approved Gene Therapy for Duchenne Muscular Dystrophy

3 ARTICLES

2w ago

New Data Confirms Low Risk of Severe Side Effects for Alzheimer’s Drug Lecanemab

3 ARTICLES

2w ago

Migraine Drug Ubrogepant Found to Ease Early Symptoms Before Headache Onset

3 ARTICLES

3w ago

Study Rules Out Mystery Brain Disease in New Brunswick, Citing Misdiagnoses

5 ARTICLES

3w ago

HIV Drugs Linked to Reduced Alzheimer’s Risk in Landmark Study

4 ARTICLES

3w ago

Study Finds Alzheimer’s Risk Disclosure Reduces Anxiety but Dampens Motivation for Healthy Habits

4 ARTICLES

3w ago

New Iontronic Micropipette Reveals Astrocyte-First Brain Activation

6 ARTICLES

4w ago

Retinal Scans Show Early Parkinson’s Detection Potential

7 ARTICLES

last mo.

Stem Cell Therapies for Parkinson’s Show Safety and Early Effectiveness in Trials

3 ARTICLES

last mo.

Leqembi Approved by European Regulators for Early-Stage Alzheimer's Treatment

Particle.news

Neurology

EHR-Based Screening Nearly Doubles Mental Health Assessments in Epilepsy Care

FDA Approves First Blood Test for Alzheimer’s Diagnosis

NIH-Led CBI-M Framework Modernizes Traumatic Brain Injury Diagnosis After 51 Years

Researchers Uncover Brain Ion Channel's Role in Molecular Memory

FDA Approves First Blood Test for Early Alzheimer’s Diagnosis in Symptomatic Adults

FDA Approves First Blood Test for Alzheimer’s Diagnosis

UCSF Research Advances Prenatal Therapy for Spinal Muscular Atrophy

AAN Highlights Gaps in Evidence for FDA-Approved Gene Therapy for Duchenne Muscular Dystrophy

Ubrogepant Shows Promise in Treating Early Migraine Symptoms

Stanford Study Uncovers Reversible Brain Fog Caused by CAR-T Cell Therapy

Never miss stories about

Neurology

HIV Drugs Linked to Lower Alzheimer’s Risk, Prompting Calls for Clinical Trials

New Data Confirms Low Risk of Severe Side Effects for Alzheimer’s Drug Lecanemab

Migraine Drug Ubrogepant Found to Ease Early Symptoms Before Headache Onset

Study Rules Out Mystery Brain Disease in New Brunswick, Citing Misdiagnoses

HIV Drugs Linked to Reduced Alzheimer’s Risk in Landmark Study

Study Finds Alzheimer’s Risk Disclosure Reduces Anxiety but Dampens Motivation for Healthy Habits

New Iontronic Micropipette Reveals Astrocyte-First Brain Activation

Retinal Scans Show Early Parkinson’s Detection Potential

Stem Cell Therapies for Parkinson’s Show Safety and Early Effectiveness in Trials

Leqembi Approved by European Regulators for Early-Stage Alzheimer's Treatment

Never miss stories about

Neurology